Saffron and Resveratrol: A Natural Remedy Against Age-Related Macular Degeneration (AMD)

The Growing Challenge of AMD Age-related Macular Degeneration (AMD) represents a significant cause of vision impairment among adults in developed nations. In Canada alone, thousands of new cases are diagnosed annually, contributing to a substantial economic impact on the country's GDP. As a major health concern, the prevalence of AMD is only expected to increase, making it a critical area for intervention.

Understanding AMD and Its Consequences AMD leads to vision loss through the deterioration of the central part of the retina, known as the macula. The disease manifests in two forms: 'dry' and 'wet' AMD. The dry form is more common and characterized by the accumulation of drusen, whereas the wet form involves abnormal blood vessel growth, leading to rapid and severe vision loss. Current treatments for wet AMD are costly and invasive, highlighting the need for more accessible prevention and treatment options.

The Promise of Saffron and Resveratrol in AMD Treatment Emerging research points to the beneficial effects of saffron and resveratrol, natural compounds known for their therapeutic properties, in combating AMD. These substances have shown potential in experimental models to protect against the multifaceted pathology of AMD, including oxidative stress, inflammation, and angiogenesis.

Clinical Studies and Mechanisms of Action Studies have illuminated the neuroprotective effects of saffron in AMD, with clinical trials indicating significant improvements in retinal function following saffron supplementation. Similarly, resveratrol has demonstrated protective effects across various models of retinal damage, suggesting its utility in both preventing and managing AMD.

Saffron's Impact on AMD Saffron, a spice rich in antioxidants like crocin, has shown promise in protecting retinal cells and improving vision quality in AMD patients. Its benefits are linked to its ability to regulate gene expression, protect against oxidative damage, and modulate inflammatory responses.

Resveratrol: A Multi-faceted Protector Resveratrol, found in grapes and red wine, has emerged as a powerful ally in eye health. Its antioxidant, anti-inflammatory, and anti-angiogenic properties make it a valuable component in addressing the complex mechanisms underlying AMD.

The Synergistic Power of Saffron and Resveratrol Combining saffron and resveratrol could offer a comprehensive approach to managing AMD, leveraging their mutual benefits to provide enhanced protection and therapeutic effects. This synergy represents a promising direction for future AMD treatments.

Towards a Brighter Future for AMD Patients The potential of saffron and resveratrol in combating AMD offers hope for those affected by this debilitating condition. As research continues to unfold, the promise of natural, accessible solutions for AMD becomes ever more tangible, paving the way for innovative treatments that could significantly improve the lives of millions worldwide.

Conclusion: Natural Solutions at the Forefront of AMD Treatment The exploration of natural compounds like saffron and resveratrol marks a significant advancement in the fight against AMD. By harnessing their protective and therapeutic properties, we move closer to a future where effective, non-invasive treatments for AMD are readily available, offering new hope for preserving vision and enhancing the quality of life for those affected by this prevalent eye disease.


Macular degeneration references: 

1-Brown et al,. 2005. Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol. 2005 Jun;40(3):277-87.

2-Sheu et al,. 2010. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J Ocul Pharmacol Ther. 2010 Jun;26(3):231-6.

3-Albani et al,. 2013. Synergism between resveratrol and crocin for protection of human neuroblastoma SHSY-5Y cells against oxidative stress. Natural Products at a Crossroad: Current and Future Directions. American Society of Pharmacognosy, 2013 Annual Meeting, Missouri.

4-Piraee et al,. 2012. Synergistic cytoprotective effects of crocin (CRN) and resveratrol (RSV) on primary human retinal pigmentepithelium (RPE) cells. International Congress on Natural Products Research 2012 Aug (ICNPR 2012), New York.

5-Falsini et al,. 2010. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6118-6124.

6-Piccardi et al,.2012. A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: sustained benefits to central retinal function. Evid Based Complement Alternat Med. 2012 Jul:429124. doi: 10.1155/2012/429124.

7-Marangoni et al,. 2013. Functional effect of Saffron supplementation and risk genotypes in early age-related macular degeneration: a preliminary report. J Transl Med. 2013 Sep;11:228. doi: 10.1186/1479-5876-11-228.

8-Marco et al,. 2013. The time course of action of two neuroprotectants, dietary saffron and photobiomodulation, assessed in the rat retina. Am J Neurodegener Dis. 2013 Sep;2(3):208-20.

9-Xuan et al,1990. Effects of crocin analogs on ocular blood flow and retinal function. J Ocul Pharmacol Ther. 1999 Apr;15(2):143-52.

10-Laabich et al,. 2006. Protective effect of crocin against blue light- and white light-mediated photoreceptor cell death in bovine and primate retinal primary cell culture. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3156-63.

11-Thomas et al,. 2007.Visual functional effects of constant blue light in a retinal degenerate rat model. Photochem Photobiol. 2007 May-Jun;83(3):759-65.

12-Ochiai T, Soeda S, Ohno S, Tanaka H, Shoyama Y, Shimeno H. Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signaling by increasing glutathione synthesis. Neurochem Int. 2004 Apr;44(5):321–330.

13-Soeda et al,. 2001. Crocin suppresses tumor necrosis factor-alpha-induced cell death of neuronally differentiated PC-12 cells. Life Sci. 2001 Nov;69(24):2887-98.

14-Maccarone et al,. 2008. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1254-61.

15-Natoli et al,. 2010.  Gene and noncoding RNA regulation underlying photoreceptor protection: microarray study of dietary antioxidant saffron and photobiomodulation in rat retina. Mol Vis. 2010 Sep;16:1801-22.

16-Xi et al,. 2007. Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats. Phytomedicine. 2007 Sep;14(9):633-6.

17-Asai et al,. 2005. Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. J Agric Food Chem. 2005 Sep;53(18):7302-6.

18-Yamauchi et al,. 2011. Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. Eur J Pharmacol. 3011 Jan;650(1):110-119.

19-Ishizuka et al,. 2013. Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice. Eur J Pharmacol. 2013 Mar;703(1-3):1-10. doi: 10.1016/j.ejphar.2013.02.007.

20-Umigai et al,. 2012. Crocetin, a carotenoid derivative, inhibits VEGF-induced angiogenesis via suppression of p38 phosphorylation. Curr Neurovasc Res. 2012 May;9(2):102-9.

21- Ghahghaei et al,. 2013. The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro. Cell Mol Biol Lett. 2013 Sep;18(3):328-39. doi: 10.2478/s11658-013-0092-1.

22-Papandreou et al,. 2006. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem. 2006 Nov;54(23):8762-8.

23-Mansoor et al,. 2009. Inhibition of apoptosis in human retinal pigment epithelial cells treated with benzo(e)pyrene, a toxiccomponent of cigarette smoke. Invest Ophthalmol Vis Sci. 2010 May;51(5):2601-7. doi: 10.1167/iovs.09-4121.

24-Khan et al,. 2010. Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway. Am J Pathol. 2010 May;177(1):48-492.

25-Chan et al,. 2013. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways. PLoS One. 2013 Feb;8(2):e56819. doi: 10.1371/journal.pone.0056819.

26-Zheng et al, 2010.Resveratrol protects human lens epithelial cells against H2O2-induced oxidative stress by increasing catalase, SOD-1, and HO-1 expression. Mol Vis. 2010 Aug ;16:1467-74.

27-Kubota et al,. 2010. Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation. Am J Pathol. 2010Aug;177(4):1725-31.

28-Pintea et al,. 2011. Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells. J Ocul Pharmacol Ther. 2011 Aug;27(4):315-21.

29-Sheu et al,. 2013. Resveratrol stimulates mitochondrial bioenergetics to protect retinal pigment epithelial cells from oxidative damage. Invest Ophthalmol Vis Sci. 2013 Sep;54(9):6426-38. doi: 10.1167/iovs.13-12024.

30-Kubota et al,. 2009. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest Ophthalmol Vis Sci. 2009 Mar;50(7):3512-9.

31-Kim and Suh,. 2010. Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy. Korean J Ophthalmol. 2010 Apr;24(2):108-18.

32-Li et al,.2012. Endoplasmic reticulum stress in retinal vascular degeneration: protective role of resveratrol. Invest Ophthalmol Vis Sci. 2012 May;53(6):3241-9. doi: 10.1167/iovs.11-8406.

33-Mimura et al,. 2013. The role of SIRT1 in ocular aging. Exp Eye Res. 2013 Nov;116:17-26. doi: 10.1016/j.exer.2013.07.017.

34- Khan et al,. 2012. SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Front Cell Neurosci. 2012 Dec;6:63. doi: 10.3389/fncel.2012.00063.

35-Qin et al,. 2013. Resveratrol protects RPE cells from sodium iodate by modulating PPARα and PPARδ. Exp Eye Res. 2013 Dec;118C:100-108. doi: 10.1016/j.exer.2013.11.010.

36- Pasovic et al. 2014. Antioxidants Improve the Viability of Stored Adult Retinal Pigment Epithelial-19 Cultures. Ophthalmol Ther. 2014 Mar 29.

37-Dugas et al,. 2010. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur J Nutr. 2010 Mar; 49(7):435-46.

38-Balaiya et al,. 2013. Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells. Mol Vis. 2013 Nov;19:2385-92.

39-Richer et al,. 2013. Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement. Nutrients. 2013 Jun;5(6):1989-2005. doi: 10.3390/nu5061989.

40-Cao et al,. 2013. SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway. Braz J Med Biol Res. 2013 Aug;46(8):659-69. doi: 10.1590/1414-431X20132903.

41-Hua et al,. 2011. Resveratrol inhibits pathologic retinal neovascularization in Vldlr-/ – Mice. Invest Ophthalmol Vis Sci. 2011 Apr;52(5):2809-26.

42-Bråkenhielm et al,. 2001.Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 2001 Aug;15(10):1798-800.

43-Nagai N1 et al., 2014. Resveratrol prevents the development of choroidal neovascularization by modulating AMP-activated protein kinase in macrophages and other cell types. J Nutr Biochem. 2014 Ju; pii: S0955-2863(14)00132-6. doi: 10.1016/j.jnutbio.2014.05.015.

44-Magnussen et al,. 2010. VEGF-A165b is cytoprotective and antiangiogenic in the retina. Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4273-81. doi: 10.1167/iovs.09-4296.

45-Nishijima et al,. 2007.Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol. 2007 Jul;171(1):53-67.



Reading next

Leave a comment

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.